Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
folic acid + calcium + vitamin D3
- Development stage
- Phase 3
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
This combination drug is used to treat calcium deficiency and vitamin D deficiency. **Calcium** is essential for bone health, **Vitamin D3 (Cholecalciferol)** helps the body absorb calcium, and **Folic Acid** is crucial for cell production and preventing birth defects.
- Brand names
- Naari CalCF-CcmCcdcalCalmafab-CCMAppcalClorocalWellcalAdorcal-CCCCM
- Other names
- Calcium Citrate Malate + Vitamin D3 + Folic Acid
02
Targets
VDR (Vitamin D receptor)CaV (Voltage-gated calcium channel protein complex)FOLR1 (FRα)
Beyond the preview
Go deeper on folic acid + calcium + vitamin D3.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on folic acid + calcium + vitamin D3.